Crossmark

Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE

Crossref DOI link: https://doi.org/10.1186/s12969-021-00627-w

Published Online: 2021-08-30

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gilbert, Mileka https://orcid.org/0000-0002-3685-3764
Goilav, Beatrice

Hsu, Joyce J.

Nietert, Paul J.

Meidan, Esra

Chua, Annabelle

Ardoin, Stacy P.

Wenderfer, Scott E.

von Scheven, Emily

Ruth, Natasha M.

,
License Information

Text and Data Mining valid from 2021-08-30

Version of Record valid from 2021-08-30
More Information

Article History

Received: 31 March 2021

Accepted: 24 July 2021

First Online: 30 August 2021

Declarations

:

: Internal Review Board exemption for study was obtained at Nationwide Children’s Hospital, IRB # IRB15-00843.

: Not applicable.

: The authors have no financial competing interests.

Document is current

Any future updates will be listed below